{"data": [{"news_url": "https://seekingalpha.com/article/4358509-why-moderna-may-trouble-trading-above-100", "image_url": "https://cdn.snapi.dev/images/v1/u/8/biotech21.jpg", "title": "Why Moderna May Have Trouble Trading Above $100", "text": "Why Moderna May Have Trouble Trading Above $100", "source_name": "Seeking Alpha", "date": "Tue, 14 Jul 2020 22:59:48 -0400", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.youtube.com/watch?v=VcUMHmIMKkg", "image_url": "https://cdn.snapi.dev/images/v1/4/a/moderna-vaccine-produced-antibodies-in-all-patients-tested.jpg", "title": "Moderna Vaccine Produced Antibodies in All Patients Tested", "text": "We have some progress on the race for a coronavirus vaccine. Moderna Inc. says its initial safety trials for its drug produced encouraging results, paving the way for final tests within the month. Bloomberg\u2019s Jodi Schneider reports on \u201cBloomberg Daybreak: Asia.\u201d", "source_name": "Bloomberg Markets and Finance", "date": "Tue, 14 Jul 2020 21:04:04 -0400", "topics": [], "sentiment": "Positive", "type": "Video", "tickers": ["MRNA"]}, {"news_url": "https://www.forbes.com/sites/siladityaray/2020/07/14/modernas-covid-vaccine-candidate-elicits-robust-antibody-response-in-all-participants-in-first-trial/", "image_url": "https://cdn.snapi.dev/images/v1/t/g/tgfre4323.jpg", "title": "Moderna\u2019s Covid Vaccine Candidate Elicits \u2018Robust\u2019 Antibody Response In All Participants In First Trial", "text": "Antibody levels observed were on the upper half of the scale seen among patients who\u2019ve recovered from the disease.", "source_name": "Forbes", "date": "Tue, 14 Jul 2020 18:18:12 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.cnbc.com/2020/07/14/stock-market-futures-open-to-close-news.html", "image_url": "https://cdn.snapi.dev/images/v1/r/u/106567493-1591393269633gettyimages-1215439483.jpeg", "title": "Dow futures jump 300 points after Moderna says its vaccine produces antibodies to coronavirus", "text": "Stocks directly tied to an economic reopening jumped following the vaccine news.", "source_name": "CNBC", "date": "Tue, 14 Jul 2020 18:07:10 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.youtube.com/watch?v=BNqoa3aVFx8", "image_url": "https://cdn.snapi.dev/images/v1/e/f/moderna-releases-covid-19-vaccine-phase-1-interim-results.jpg", "title": "Moderna releases Covid-19 vaccine phase 1 interim results", "text": "CNBC's Meg Tirrell reports on Moderna's phase 1 vaccine results.", "source_name": "CNBC Television", "date": "Tue, 14 Jul 2020 18:06:43 -0400", "topics": [], "sentiment": "Positive", "type": "Video", "tickers": ["MRNA"]}, {"news_url": "https://www.benzinga.com/news/20/07/16622200/modernas-stock-jumps-after-coronavirus-vaccine-shows-positive-results-in-phase-1-clinical-trial", "image_url": "https://cdn.snapi.dev/images/v1/t/g/vaccine-5074670-1920-0.jpg", "title": "Moderna's Stock Jumps After Coronavirus Vaccine Shows Positive Results In Phase 1 Clinical Trial", "text": "Moderna Inc (NASDAQ: MRNA) is getting a big boost in Tuesday's after-hours session following a positive development on the company's coronavirus vaccine.", "source_name": "Benzinga", "date": "Tue, 14 Jul 2020 17:25:13 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.investors.com/news/technology/coronavirus-vaccine-moderna-says-drug-triggered-immune-response/", "image_url": "https://cdn.snapi.dev/images/v1/a/8/biotech17.jpg", "title": "Moderna Stock Pops After Coronavirus Vaccine Triggers Immune Response", "text": "Moderna's coronavirus vaccine triggered immune responses across three varying doses in a Phase 1 study, the biotech company said late Tuesday. Most side effects were mild to moderate.", "source_name": "Investors Business Daily", "date": "Tue, 14 Jul 2020 17:12:44 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.reuters.com/article/us-health-coronavirus-moderna/moderna-phase-1-results-show-coronavirus-vaccine-safe-induces-immune-response-idUSKCN24F2SW", "image_url": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5714322fgettyimages-1209372926jpgw700opresize.jpg", "title": "Moderna Phase 1 results show coronavirus vaccine safe, induces immune response", "text": "Moderna Inc\u2019s (MRNA.O) experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday.", "source_name": "Reuters", "date": "Tue, 14 Jul 2020 17:03:00 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.cnbc.com/2020/07/14/moderna-says-its-coronavirus-vaccine-trial-produced-robust-immune-response-in-all-patients.html", "image_url": "https://cdn.snapi.dev/images/v1/p/o/106601819-1593715914799ap-20139541521728.jpg", "title": "Moderna says its coronavirus vaccine trial produced 'robust' immune response in all patients", "text": "Moderna's potential vaccine to prevent Covid-19 produced neutralizing antibodies in all 45 patients in its early stage human trial, according to newly released data.", "source_name": "CNBC", "date": "Tue, 14 Jul 2020 17:00:58 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/07/14/moderna-sets-date-for-start-of-coronavirus-vaccine.aspx", "image_url": "https://cdn.snapi.dev/images/v1/p/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5822832fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg", "title": "Moderna Sets Date for Start of Coronavirus Vaccine Phase 3 Trial", "text": "The company might just begin the testing this month after all.", "source_name": "The Motley Fool", "date": "Tue, 14 Jul 2020 14:50:00 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/07/14/everything-you-need-to-know-about-modernas-valuati.aspx", "image_url": "https://cdn.snapi.dev/images/v1/0/n/oak1wedff.jpg", "title": "Everything You Need to Know About Moderna's Valuation", "text": "Shares of the coronavirus vaccine maker are up 276% this year.", "source_name": "The Motley Fool", "date": "Tue, 14 Jul 2020 14:00:00 -0400", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.youtube.com/watch?v=_oTP1VDHf3M", "image_url": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5703842fvaccinationjpgw700opresize.jpg", "title": "Coronavirus vaccine production to begin this summer: Report", "text": "Fox News medical contributor Dr. Marc Siegel discusses the potential launch of coronavirus vaccine production and Dr. Fauci blaming coronavirus spikes on shutdown limitations.", "source_name": "Fox Business", "date": "Tue, 14 Jul 2020 12:06:33 -0400", "topics": [], "sentiment": "Neutral", "type": "Video", "tickers": ["ABBV", "BMY", "GILD", "GSK", "JNJ", "MRNA", "PFE"]}, {"news_url": "https://www.cnbc.com/2020/07/14/moderna-will-begin-late-stage-coronavirus-vaccine-trial-on-july-27.html", "image_url": "https://cdn.snapi.dev/images/v1/h/c/106542677-15898329812020-05-18t172547z-83299489-rc25rg9kzp68-rtrmadp-0-health-coronavirus-moderna.jpeg", "title": "Moderna will begin late-stage coronavirus vaccine trial on July 27", "text": "Moderna will begin its late-stage trial testing a potential vaccine to prevent Covid-19 on July 27, according to a posting published Tuesday on ClinicalTrials.gov.", "source_name": "CNBC", "date": "Tue, 14 Jul 2020 11:18:09 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/07/14/moderna-graduates-to-major-nasdaq-index.aspx", "image_url": "https://cdn.snapi.dev/images/v1/w/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5822152fmoderna-buildingjpgw700opresize.jpg", "title": "Moderna Graduates to a Major Nasdaq Index", "text": "The white-hot biotech will become even more prominent by being included in the Nasdaq 100 Large-Cap Index.", "source_name": "The Motley Fool", "date": "Tue, 14 Jul 2020 10:00:00 -0400", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.zacks.com/stock/news/1003660/moderna-rises-on-bullish-sentiments-for-coronavirus-vaccine", "image_url": "https://cdn.snapi.dev/images/v1/q/2/biotech39.jpg", "title": "Moderna Rises on Bullish Sentiments for Coronavirus Vaccine", "text": "Moderna's (MRNA) progress with its coronavirus vaccine is boosting the company's growth prospects. Some analysts expect its coronavirus vaccine to generate more than $5 billion in sales.", "source_name": "Zacks Investment Research", "date": "Tue, 14 Jul 2020 08:44:00 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.zacks.com/stock/news/1003616/race-to-coronavirus-vaccine-heats-up-5-stocks-in-spotlight", "image_url": "https://cdn.snapi.dev/images/v1/g/r/biotech34-2.jpg", "title": "Race to Coronavirus Vaccine Heats Up: 5 Stocks in Spotlight", "text": "Two experimental coronavirus vaccines, manufactured jointly by Pfizer and BioNTech, have received fast track status from the FDA.", "source_name": "Zacks Investment Research", "date": "Tue, 14 Jul 2020 08:11:00 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["BNTX", "JNJ", "MRNA", "NVAX", "PFE"]}, {"news_url": "https://www.benzinga.com/government/20/07/16610802/trump-administration-expects-coronavirus-vaccine-production-to-start-by-the-end-of-summer", "image_url": "https://cdn.snapi.dev/images/v1/l/a/lab-0.jpeg", "title": "Trump Administration Expects Coronavirus Vaccine Production To Start By The End Of Summer", "text": "A senior functionary of President DonaldTrump\u2019s administration has\u00a0disclosed\u00a0that health officials and drugmakers in the United States are expecting the production of a COVID-19 vaccine to begin by the end of summer.", "source_name": "Benzinga", "date": "Tue, 14 Jul 2020 07:58:38 -0400", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["JNJ", "MRNA"]}, {"news_url": "https://www.zacks.com/stock/news/1003584/fda-aims-to-fast-track-coronavirus-vaccine-3-stocks-in-focus", "image_url": "https://cdn.snapi.dev/images/v1/s/9/biotech29.jpg", "title": "FDA Aims to Fast-Track Coronavirus Vaccine: 3 Stocks in Focus", "text": "Vaccine seems to be the only hope now to counter the pandemic given that millions of new cases of coronavirus are being reported every day.", "source_name": "Zacks Investment Research", "date": "Tue, 14 Jul 2020 07:42:00 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["GILD", "LLY", "MRNA"]}, {"news_url": "https://www.investors.com/news/technology/mrna-stock-buy-now/", "image_url": "https://cdn.snapi.dev/images/v1/w/p/biotech27.jpg", "title": "Moderna Is Leading The Coronavirus Vaccine Race \u2014 But Is MRNA Stock A Buy?", "text": "Moderna has emerged as a strong competitor in the race for a coronavirus vaccine. But Moderna stock remains on a wild ride in 2020 as the need for a Covid-19 vaccine grows.", "source_name": "Investors Business Daily", "date": "Tue, 14 Jul 2020 07:15:56 -0400", "topics": [], "sentiment": "Negative", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/07/14/are-there-warning-signs-about-modernas-covid-19-va.aspx", "image_url": "https://cdn.snapi.dev/images/v1/n/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5820522fscientist-with-hand-up-in-restricted-areajpgw700opresize.jpg", "title": "Are There Warning Signs About Moderna's COVID-19 Vaccine Program?", "text": "Some sources are complaining that Moderna is attempting to \"test every boundary\" with its COVID-19 vaccine development. But that might not be a bad thing.", "source_name": "The Motley Fool", "date": "Tue, 14 Jul 2020 06:47:00 -0400", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}]}